By expenditures
| Name | Title | Type |
|---|---|---|
| Matthew Walters | Director of Accounting | Auditee |
| Dave Berglund | Associate Vice President for Finance | Auditee |
| Patricia M Langer | Vice President of Administration and Finance | Auditee |
| Deirdre Hodgson | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 371195 | 2025 | 2025-10-23 | CLIFTONLARSON ALLEN LLP | $10.04M |
| 323740 | 2024 | 2024-10-03 | Cliftonlarsonallen LLP | $10.80M |
| 6092 | 2023 | 2023-12-11 | Cliftonlarsonallen LLP | $11.96M |
| 50913 | 2022 | 2022-11-09 | Cliftonlarsonallen LLP | $15.33M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 371195 | 2025 | 2025-10-23 | 1161274 | 2025-004 | Material Weakness | Yes | I |
| 371195 | 2025 | 2025-10-23 | 1161273 | 2025-003 | Material Weakness | Yes | N |
| 371195 | 2025 | 2025-10-23 | 1161272 | 2025-002 | Material Weakness | Yes | N |
| 371195 | 2025 | 2025-10-23 | 1161271 | 2025-002 | Material Weakness | Yes | N |
| 371195 | 2025 | 2025-10-23 | 1161270 | 2025-002 | Material Weakness | Yes | N |
| 371195 | 2025 | 2025-10-23 | 1161269 | 2025-001 | Material Weakness | Yes | L |
| 371195 | 2025 | 2025-10-23 | 1161268 | 2025-001 | Material Weakness | Yes | L |
| 371195 | 2025 | 2025-10-23 | 1161267 | 2025-001 | Material Weakness | Yes | L |
| 323740 | 2024 | 2024-10-03 | 1078133 | 2024-001 | Significant Deficiency | - | N |
| 323740 | 2024 | 2024-10-03 | 1078132 | 2024-001 | Significant Deficiency | - | N |
| 323740 | 2024 | 2024-10-03 | 1078131 | 2024-001 | Significant Deficiency | - | N |
| 323740 | 2024 | 2024-10-03 | 501691 | 2024-001 | Significant Deficiency | - | N |
| 323740 | 2024 | 2024-10-03 | 501690 | 2024-001 | Significant Deficiency | - | N |
| 323740 | 2024 | 2024-10-03 | 501689 | 2024-001 | Significant Deficiency | - | N |
| 6092 | 2023 | 2023-12-11 | 580309 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 580308 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 580307 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 580306 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 580305 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 580304 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 3867 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 3866 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 3865 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 3864 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 3863 | 2023-001 | Significant Deficiency | - | L |
| 6092 | 2023 | 2023-12-11 | 3862 | 2023-001 | Significant Deficiency | - | L |